Mark S. Blumenkranz SEC insider filings

Historical public-company ownership and transaction filings, with links to the original SEC records.

What the SEC filings show

Mark S. Blumenkranz is named as a reporting owner in 12 source-backed SEC filings in this collection, associated with 2 public-company issuers. The most recent included filing was submitted Aug 12, 2026.

Filings may report stock transactions or holdings at a particular time. They do not establish the person's current share balance, portfolio value, total net worth, or whether a transaction was an open-market purchase or sale.

Source filings
12
Issuers represented
2
Filings with transactions
12
Filings with holdings
10

Recent SEC source documents

A selection of the latest 3 relevant source filings. Counts describe reported rows in the filing, not verified trades, economic proceeds, or personal profits. Older filings and amendments may contain different information.

FiledIssuerReported relationshipRowsOriginal SEC filing
Aug 12, 2026Annexon, Inc.Director1 transaction / 0 holdingForm 4 · 0001614869-26-000004
Jun 15, 2015Avalanche Biotechnologies, Inc.Director1 transaction / 3 holdingForm 4 · 0001181431-15-008323
Jun 11, 2015Avalanche Biotechnologies, Inc.Director4 transaction / 3 holdingForm 4 · 0001181431-15-008178

How to interpret this evidence

SEC Forms 3, 4 and 5 disclose certain ownership and transaction observations. Reporting dates, beneficial ownership, derivative instruments, indirect positions and amendments can affect interpretation. Figures here are counts of filing records, not independent valuations. Exact total net worth is not publicly known from this filing record.

Browse this reporting owner's SEC filing history

Explore people and ownership research